Jen Zoltoski, CPA

Vp, Corporate Controller at Avalo Therapeutics

Jen Zoltoski, CPA, has a diverse work experience spanning several organizations and roles. Jen began their career as an intern in Audit Services at Ernst & Young in 2012. Jen then joined the University of Richmond as a Student-Athlete from 2009 to 2013. In 2013, Jen joined EY as a Staff in Audit Services and progressed to the role of Senior in both Audit Services and Financial Accounting Advisory Services (FAAS). Jen became a Manager in FAAS in 2018 before leaving EY.

In 2018, Jen joined Avalo Therapeutics as a Senior Manager of SEC Reporting, overseeing the company's financial reporting and compliance with regulatory requirements. Jen then took on the role of Director of SEC Reporting in 2020 before being promoted to Corporate Controller in 2021. Throughout their career, Jen has demonstrated expertise in financial accounting, auditing, and SEC reporting.

Jen Zoltoski, CPA, received their Bachelor of Science in Business Administration (BSBA) degree in Accounting from the University of Richmond - Robins School of Business in 2013. Jen attended the university from 2009 to 2013. In 2011, they had a brief experience studying at the Prague University of Economics and Business. Prior to their university education, Jen Zoltoski attended The John Carroll School from 2005 to 2009, although the specific degree or field of study they pursued during this time is not provided.

Links


Org chart